Robust China ecosystem to elevate globalization

A1 During the 14th Five-Year Plan period (2021-25), China will be committed to navigating a high-level opening-up to the outside world. In the field of healthcare, the Chinese government has stepped up investment in building a solid public health and contagion prevention system and new medical infrastructure, creating fresh development opportunities for multinational companies.

China's high-level opening-up has further reinforced our confidence and determination to continue to extensively explore this lucrative market.

A2 Thanks to scientific and technological innovation, which has injected strong momentum into high-quality development, we are confident in the prospects of China's economic development.

The rapid growth of new-generation information technologies has generated continuous improvements in business scale, quality and efficiency in many sectors.

A3 With the rapid growth in China, Carestream has maintained, especially over the past five years, double-digit growth every year. The Chinese market has risen to be the group's largest single biggest market worldwide.

In 2022, Carestream is going to deepen its localization strategy of products, channels, services and supply chains to meet growing market demand from high-end, primary and nonpublic medical services, and support the development of the Healthy China 2030 Initiative.

A4 It is impossible for a company to achieve sustainable growth if the entire industry fails to thrive and develop in a healthy fashion. It is our hope to develop and cooperate with partners in various fields to open up a new chapter in the development of medical imaging.

Carestream has cultivated medical imaging technology for many years. We are keen to maintain our leading position by pioneering in and developing a mass volume of affordable and serviceable products in the next decade.

A5 Amid the world's fight against the COVID-19 pandemic, China's status and influence in the global economic landscape have been continuously rising.

The importance of the Chinese market is not only determined by its huge size, but is demonstrated to a larger extent by its role as a global innovation engine.

We are confident in the development of China's medical industry and will increase investment in this market. Therefore, we will make further efforts in local innovation, expand our product matrix and apply intelligent imaging solutions for smart and precise diagnoses to improve patient experience this year.